Inhibitors of indoleamine 2,3-dioxygenase
The invention relates to a compound of Formula (I), or pharmaceutically acceptable enantiomers, or salts thereof. The present invention also relates to the use of compounds of Formula (I) as selectiveinhibitors of indoleamine 2,3-dioxygenase. The invention also relates to the use of the compounds of...
Gespeichert in:
Hauptverfasser: | , , , , , , , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The invention relates to a compound of Formula (I), or pharmaceutically acceptable enantiomers, or salts thereof. The present invention also relates to the use of compounds of Formula (I) as selectiveinhibitors of indoleamine 2,3-dioxygenase. The invention also relates to the use of the compounds of Formula (I) for the treatment or prevention of diseases cancer, infections, central nervous systemdisease or disorder, and immune-related disorders, either as a single agent or in combination with other therapies.
本发明涉及式I的化合物或其药学上可接受的对映异构体或盐。本发明还涉及式(I)的化合物作为吲哚胺2,3-双加氧酶的选择性抑制剂的用途。本发明还涉及式(I)的化合物作为单药剂或与其他疗法组合用于治疗或预防癌症、感染、中枢神经系统疾病或障碍以及免疫相关障碍的用途。 |
---|